Infliximab for Treatment of Granulomatous Disease in Patients with Common Variable Immunodeficiency

[1] Conley ME(1999)Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) Clin Immunol 93 190-197

[2] Notarangelo LD(2005)Granulomatous disease in common variable immunodeficiency Curr Allergy Asthma Rep 5 370-375

[3] Etzioni A(2010)How I, treat common variable immune deficiency Blood 116 7-15

[4] Morimoto Y(2009)Granulomatous disease in common variable immunodeficiency Clin Immunol 133 198-207

[5] Routes JM(1997)TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease J Immunol 159 6236-6241

[6] Cunningham-Rundles C(2013)Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients J Clin Immunol 33 84-95

[7] Ardeniz O(1997)Granulomatous disease in common variable immunodeficiency Ann Intern Med 127 613-617

[8] Cunningham-Rundles C(2000)Noncaseating granulomatous disease in common variable immunodeficiency South Med J 93 631-633

[9] Mullighan CG(2005)Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature Ann Allergy Asthma Immunol 95 293-300

[10] Fanning GC(2002)TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection J Immunol 168 4620-4627

[1] Conley ME(1999)Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) Clin Immunol 93 190-197

[2] Notarangelo LD(2005)Granulomatous disease in common variable immunodeficiency Curr Allergy Asthma Rep 5 370-375

[3] Etzioni A(2010)How I, treat common variable immune deficiency Blood 116 7-15

[4] Morimoto Y(2009)Granulomatous disease in common variable immunodeficiency Clin Immunol 133 198-207

[5] Routes JM(1997)TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease J Immunol 159 6236-6241

[6] Cunningham-Rundles C(2013)Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients J Clin Immunol 33 84-95

[7] Ardeniz O(1997)Granulomatous disease in common variable immunodeficiency Ann Intern Med 127 613-617

[8] Cunningham-Rundles C(2000)Noncaseating granulomatous disease in common variable immunodeficiency South Med J 93 631-633

[9] Mullighan CG(2005)Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature Ann Allergy Asthma Immunol 95 293-300

[10] Fanning GC(2002)TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection J Immunol 168 4620-4627